ShortCut device study for valve-in-valve procedures
Part of Heart & circulation clinical trials.
This study tests a device called ShortCut that helps doctors perform a valve-in-valve procedure, which replaces a failing artificial heart valve without open-heart surgery. It may help people who are at risk of blocked coronary arteries during this procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 22 years or older.
- You are scheduled to have a valve-in-valve procedure using the ShortCut device.
- Your doctor has found that you are at risk for blocked coronary arteries during the procedure.
- You must be able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
This trial studies how safe and effective the NAVITOR valve is for treating narrowed aortic valves placed through a catheter (no open-heart surgery). It may be an option if you’re at intermediate-to-low surgical risk and meet heart ultrasound/CT measurements.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This study tests whether a less invasive valve replacement (TAVI) can be done safely in hospitals that don't have a full heart surgery team on site. If you have severe aortic stenosis and are 70 or older, this trial might offer a new option with a shorter recovery than open-heart surgery.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
Hear when a new Aortic Stenosis Treated With TAVI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.